Search / Trial NCT06233123

Efficacy of a Phone Application on Treatment Adherence in Asthmatic Patients in Upper Egypt

Launched by ASSIUT UNIVERSITY · Jan 22, 2024

Trial Information

Current as of October 04, 2024

Not yet recruiting

Keywords

Description

Asthma is a chronic and common disease of the airways that affects more than 339 million people globally \[1\]. According to WHO estimates, there were 417,918 deaths due to asthma at the global level and 24.8 million disability-adjusted life years (DALYs) attributable to Asthma \[2, 3\]. There is much evidence that self-care by patients with asthma has beneficial outcomes, including reduced hospital stays, reduced symptoms, and general compliance with treatments \[4-6\]. One of the approaches for promoting self-care skills in patients with asthma is to provide self-care services (i.e., prov...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Doctor-diagnosed asthma. On at least Global Initiative for Asthma (GINA) step 3 which means they will be on regular inhaled steroids.
  • No change in regular asthma treatment in the last 1 month Sufficient English-language ability to understand the text in mobile phone-delivered interventions The education level required will be at least a high school diploma.
  • Exclusion Criteria:
  • GINA step 5 asthma (complex issues, too unstable). Recent changes to asthma treatment within the last month Another chronic health condition (eg diabetes, congenital heart disease, cystic fibrosis) Patients without mobile device skills

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0